BiotechTube
Home/CellTrans/Peter Rios, PhD
PR

Peter Rios, PhD

Chief Scientific Officer

CellTrans

Therapeutic Areas

Type 1 Diabetes

CellTrans Pipeline

DrugIndicationPhase
LANTIDRA (donislecel-jujn)Type 1 Diabetes with severe hypoglycemiaApproved

Leadership Team at CellTrans

JO
José Oberholzer, MD
Founder, President & Chief Medical Officer
JM
James McGarrigle, PhD
Chief Operating Officer
GL
Giovanna La Monica, PhD
Chief Quality Officer
View full CellTrans profile